Rights and permissions
About this article
Cite this article
Oprelvekin is promising in active Crohn’s disease. Inpharma Wkly. 1197, 8 (1999). https://doi.org/10.2165/00128413-199911970-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199911970-00015